000 01240 a2200313 4500
005 20250518013112.0
264 0 _c20190227
008 201902s 0 0 eng d
022 _a1532-8708
024 7 _a10.1053/j.seminoncol.2018.08.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRamage, John
245 0 0 _aPeptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors.
_h[electronic resource]
260 _bSeminars in oncology
_c08 2018
300 _a236-248 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aHumans
650 0 4 _aIntestinal Neoplasms
_xradiotherapy
650 0 4 _aNeuroendocrine Tumors
_xradiotherapy
650 0 4 _aOctreotide
_xanalogs & derivatives
650 0 4 _aOrganometallic Compounds
_xtherapeutic use
650 0 4 _aPancreatic Neoplasms
_xradiotherapy
650 0 4 _aRadioisotopes
_xtherapeutic use
650 0 4 _aStomach Neoplasms
_xradiotherapy
700 1 _aNaraev, Boris G
700 1 _aHalfdanarson, Thorvardur R
773 0 _tSeminars in oncology
_gvol. 45
_gno. 4
_gp. 236-248
856 4 0 _uhttps://doi.org/10.1053/j.seminoncol.2018.08.004
_zAvailable from publisher's website
999 _c29152854
_d29152854